Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 4/20/2018
E.g., 4/20/2018
Title Status FDA Center Date Postedsort ascending
Routine Querying System Complete 04/19/2018
Sentinel Medical Chart Review Gap Analysis Complete 04/19/2018
Clostridium difficile Infection Following Use of Vancomycin, Fidaxomicin, or Metronidzaole Complete CDER 04/03/2018
Availability of International Normalized Ratio (INR) Laboratory Test Values and Test Procedures among Warfarin Users Complete CDER 04/03/2018
Warfarin Use Followed by International Normalized Ratio (INR) Lab Codes Complete CDER 04/02/2018
Top Ten Causes of Death Complete CDER 03/29/2018
Prevalent and Incident Use of Fingolimod Complete CDER 03/28/2018
Influenza Vaccines and Birth Outcomes Complete CBER 03/28/2018
Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users Complete CDER 03/27/2018
Testing Routine Querying Tools with Known Positive Exposure-Outcome Associations: Clostridium difficile Events After Use of Oral Clindamycin versus Penicllins Complete 03/27/2018
Prevalence and Incident Use of Promethazine Complete CDER 03/26/2018
Use of Clonzepam Complete CDER 03/26/2018
Diagnosis of Agranulocytosis Following New Use of Anti-epileptic Drugs, Clozapine, and Olanzapine Complete CDER 03/21/2018
Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate Complete CDER 03/19/2018
Counts and Prevalence of Linezolid and Vancomycin Complete CDER 03/19/2018
Use of Atrial Fibrillation Drugs Complete CDER 03/16/2018
Incident Use of Hepatitis C Virus (HCV) Drugs Complete CDER 03/13/2018
Concomitancy and Indications for Idelalisib Use Complete CDER 03/13/2018
Prevalent and Incident Use of Generic Name Kinase Inhibitors Complete CDER 03/08/2018
Incident Use of Rivaroxaban Complete CDER 03/07/2018
Automated Approaches to Anaphylaxis Case Classification Using Unstructured Data In progress 03/07/2018
Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Discontinued CDER 03/06/2018
Lybrel (Noncyclic ethinyl estradiol) and Venous Thromboembolism Complete CDER 03/05/2018
Venous Thromboembolism Following Lybrel (Noncyclic Ethinyl Estradiol) Compared with Cyclic Oral Contraceptives Complete CDER 03/05/2018
Drug Utilization Over Time for Three Drug Classes Complete CDER 03/05/2018
Sequential Surveillance for Drug Safety in a Regulatory Environment Complete 03/05/2018
Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products Complete CDER 03/02/2018
Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Complete CDER 03/02/2018
Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Complete CDER 03/01/2018
Data Quality Review and Characterization Programs v4.1.0 Complete 02/28/2018
Use of Tyrosine Kinase Inhibitors (TKIs) Complete CDER 02/28/2018
Length of Follow-up Time for New Users of Immunosuppressive Drugs Complete CDER 02/28/2018
Validation of Hodgkin’s and Non-Hodgkin’s Lymphoma in ICD-10 CM In progress 02/22/2018
Use of Antipsychotic Drugs Complete CDER 02/14/2018
TreeExtraction Documentation In progress 02/07/2018
Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use Complete CDER 02/05/2018
Ranexa (Ranolazine) and Seizures Complete CDER 02/05/2018
Prevalent and Incident Dispensings of Ranolazine Complete CDER 02/05/2018
Utilization of Sinus Stents with Mometasone Complete CDER 02/05/2018
Sinus Stents with Mometasone and Diminished Visual Acuity Complete CDER 02/05/2018
Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and Inducers Complete CDER 02/01/2018
Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3 Complete CDER 02/01/2018
Prevalent and Incident Use of SGLT2 Inhibitors Complete CDER 02/01/2018
PROMPT: Rivaroxaban Surveillance Complete CDER 01/31/2018
Antiepileptic Drug (AED) Injection Procedure Codes Complete CDER 01/31/2018
Use of Bortezomib Complete CDER 01/30/2018
Counts of Commonly used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers Complete CDER 01/29/2018
Drug and Medical Enrollment Counts Complete CDER 01/29/2018
A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Complete CDER 01/26/2018
Use of Tumor Necrosis Factor (TNF) Blocker Drugs Complete CDER 01/26/2018
Influenza Vaccines and Pregnancy Outcomes (PRISM) Complete CBER 01/26/2018
Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness Complete CDER 01/25/2018
Data Infrastructure Expansion: Developing a Mother-Infant Linkage table in the Sentinel Common Data Model (SCDM) In progress 01/25/2018
Conversion of Medicare Claims Synthetic Public Use Files (SynPUFs) to Sentinel Common Data Model (SCDM) Format In progress 01/25/2018
Molecularly Targeted Anti-Cancer Therapies Complete CDER 01/24/2018
Use of Stents Complete CDRH 01/23/2018
Exploratory Analysis of Drugs with Risk Evaluation and Mitigation Strategy (REMS) Complete CDER 01/22/2018
Stroke Diagnosis Codes Complete CDER 01/18/2018
Length of Enrollment in Pediatric Population Complete CDER 01/17/2018
Prevalent and Incident Use of Isotretinoin Complete CDER 01/16/2018
Occurrence of Selected Generic Drugs 13 Complete CDER 01/11/2018
Use of Dronedarone HCL Complete CDER 01/08/2018
Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use Complete CDER 01/07/2018
Implementation of a Randomized Controlled Trial to Improve Treatment with Oral Anticoagulants in Patients with Atrial Fibrillation (IMPACT-AFib) In progress 01/04/2018
Incident and Prevalent Dispensings of Mirabegron Complete CDER 01/01/2018
Use of Ospemifene, Boceprevir, and Telaprevir Complete CDER 12/29/2017
Use of Cabozantinib Complete CDER 12/28/2017
Postlicensure Medical Product Safety Data-Mining: Power Calculations for Bernoulli Data Complete CBER 12/22/2017
Prevalent and Incident Use of Testosterone Products Complete CDER 12/21/2017
Top 100 Procedures and Diagnoses 30 Days Surrounding Incident Warfarin Use Complete CDER 12/21/2017
Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women Complete CDER 12/20/2017
Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Complete CDER 12/19/2017
Prevalent and Incident Use of Romiplostim Complete CDER 12/18/2017
Influenza and Medical Countermeasures Feasibility Complete CDER 12/17/2017
Suicide Diagnoses Complete CDER 12/15/2017